Cargando…

Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781

Detalles Bibliográficos
Autores principales: van der Pluijm, Rob W., Visser, Benjamin J., Dondorp, Arjen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143316/
https://www.ncbi.nlm.nih.gov/pubmed/35629060
http://dx.doi.org/10.3390/jcm11102934
_version_ 1784715776003932160
author van der Pluijm, Rob W.
Visser, Benjamin J.
Dondorp, Arjen M.
author_facet van der Pluijm, Rob W.
Visser, Benjamin J.
Dondorp, Arjen M.
author_sort van der Pluijm, Rob W.
collection PubMed
description
format Online
Article
Text
id pubmed-9143316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91433162022-05-29 Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781 van der Pluijm, Rob W. Visser, Benjamin J. Dondorp, Arjen M. J Clin Med Comment MDPI 2022-05-23 /pmc/articles/PMC9143316/ /pubmed/35629060 http://dx.doi.org/10.3390/jcm11102934 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
van der Pluijm, Rob W.
Visser, Benjamin J.
Dondorp, Arjen M.
Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title_full Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title_fullStr Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title_full_unstemmed Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title_short Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
title_sort comment on weitzman et al. resistance to antimalarial monotherapy is cyclic. j. clin. med. 2022, 11, 781
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143316/
https://www.ncbi.nlm.nih.gov/pubmed/35629060
http://dx.doi.org/10.3390/jcm11102934
work_keys_str_mv AT vanderpluijmrobw commentonweitzmanetalresistancetoantimalarialmonotherapyiscyclicjclinmed202211781
AT visserbenjaminj commentonweitzmanetalresistancetoantimalarialmonotherapyiscyclicjclinmed202211781
AT dondorparjenm commentonweitzmanetalresistancetoantimalarialmonotherapyiscyclicjclinmed202211781